Skip to main content
OpenTrials
Completed

NCT Number: NCT02344082

Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management

This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).

Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Telemedicine

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients with a primary care provider at JHOC or EMBC
  • Patients have seen primary care provider within last 6 months
  • Patients with hemoglobin A1c greater than 9%

Exclusion criteria

  • Patients <18 years of age
  • Patients with previously established care with JHH ambulatory care pharmacist
  • Patients with communication barriers who do not have a caregiver
  • Patients with new diagnosis of diabetes
  • Patients who are pregnant or planning to become pregnant during the time of the study
  • Patients followed by Endocrinology or Diabetes Center

Treatment and study plan

Telemedicine

Other

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

Primary outcomes

  1. Change in hemoglobin A1c

    Time frame: 3 months

    A1c at 3 months - A1c at Baseline

Secondary outcomes

  1. Patient adherence to office visits (# visits attended/# of visits scheduled)

    Time frame: 3 months

    # visits attended/# of visits scheduled

  2. Pharmacist interventions (Number of pharmacist interventions (lifestyle or medication changes) made)

    Time frame: 3 months

    Number of pharmacist interventions (lifestyle or medication changes) made

  3. Patient satisfaction (Based on survey results)

    Time frame: 3 months

    Based on survey results at final pharmacy clinic visit

  4. Telemedicine in Usual Care (Percent of patients who receive telephone call under usual care)

    Time frame: 3 months

    Percent of patients who receive telephone call under usual care

  5. Telemedicine Adherence (Percent of telephone encounters completed in intervention arm)

    Time frame: 3 months

    Percent of telephone encounters completed in intervention arm

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Registry information

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jan 22, 2015
Registry last updated
Dec 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.